share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

諾瓦瓦克斯醫藥 | 4:持股變動聲明-董事 Rodgers Richard J
美股SEC公告 ·  01/02 13:57

Moomoo AI 已提取核心訊息

On October 29, 2024, Rodgers Richard J, associated with Novavax, acquired 3,800 shares of Common Stock at $0 per share through the exercise or conversion of a derivative security. This transaction was reported as completed.Following the acquisition, Rodgers Richard J's direct ownership of Novavax Common Stock increased to 14,270 shares. The transaction was executed under the code 'M', indicating it resulted from the exercise or conversion of a derivative security rather than an open market purchase.
On October 29, 2024, Rodgers Richard J, associated with Novavax, acquired 3,800 shares of Common Stock at $0 per share through the exercise or conversion of a derivative security. This transaction was reported as completed.Following the acquisition, Rodgers Richard J's direct ownership of Novavax Common Stock increased to 14,270 shares. The transaction was executed under the code 'M', indicating it resulted from the exercise or conversion of a derivative security rather than an open market purchase.
在2024年10月29日,與諾瓦瓦克斯醫藥有關的Rodgers Richard J通過執行或轉換衍生證券以每股0美元的價格收購了3,800股普通股。此交易已報告完成。收購後,Rodgers Richard J對諾瓦瓦克斯醫藥普通股的直接持有量增加至14,270股。該交易在代碼'M'下執行,表明其源於衍生證券的執行或轉換,而不是公開市場購買。
在2024年10月29日,與諾瓦瓦克斯醫藥有關的Rodgers Richard J通過執行或轉換衍生證券以每股0美元的價格收購了3,800股普通股。此交易已報告完成。收購後,Rodgers Richard J對諾瓦瓦克斯醫藥普通股的直接持有量增加至14,270股。該交易在代碼'M'下執行,表明其源於衍生證券的執行或轉換,而不是公開市場購買。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息